Research Trends

  Hematology is the medical branch of medicine concerned primarily with the study of this specific type of blood-related disorder. Blood vessels are the sites through which oxygen and other nutrients are delivered to all parts of the body. Hematologists are involved in the diagnosis, treatments, and monitoring of disorders that have a connection with the circulatory system, the bone marrow, or the lymphatic system. There are basically two branches of this field: Hematology, which deals primarily with the collection and evaluation of blood samples; and Pediatric Hematology, which involves the care of infants, children, and people with hematological disorders. The term "hematology" actually refers to the science of blood. The science of hematology is also commonly referred to as "blood and platelet." A Hematologist's major task is to monitor the functions of the bone marrow and to check for evidence of leukemia, cancer, infections, thrombocytopenia, and leukemi

  In the regions of pharmacology, science, and medication, drug discovery is basically the method by which new planned drug competitors are found. During the cycle, various advances are taken to decrease the dangers related with such revelations, from early innovative work to administrative endorsements, and showcasing procedures. It can require years and high venture for another drug to arrive at the market. The expense of drug improvement was US$ 2.6 billion, which included normal cash based expenses of US$ 1.4 billion and time expenses of US$ 1.2 billion, as indicated by an examination by the Tufts Center for the Study of Drug Development distributed in the Journal of Health Economics in May 2019. In this way, major parts in the market are centered around viable R&D of new drugs. For example, in March 2021, Kyowa Kirin Co, Ltd., a Japan-based drug and biotechnology organization, worked together with Harvard University to speed up discovery and beginning phase advancement in tran

  Thrombocytopenia or also known as "hardening of the arteries" is a potentially serious but often ignored cardiovascular illness. When blood flow to the heart is decreased, it can eventually lead to a condition called "atherosclerosis." Atherosclerosis is considered a primary, or primary form of the disease. In milder forms of the illness, it can cause blood clots that deposit in the arteries. While thrombocytopenia can affect men and women of all ages, it is more common in middle-aged and older people. Symptoms of the condition include shortness of breath or fatigue, swelling in the legs, nausea and vomiting, weakness, and frequent urination. Diagnosis of thrombocytopenia involves several tests, including blood tests, chest x-rays, and blood test results. The most common thrombocytopenia treatment is antiplatelet treatment and in more severe cases, surgery. There are some lifestyle changes that can help. For example, smokers should quit and dieters should cut d